fluorine F 18 W372
Term · Oncology and biomedicine · MLC-T-ONC-013700
A radiotracer composed of W372 radiolabeled with the radioisotope fluorine F 18, with potential amyloid-beta (Abeta) peptide imaging activity upon positron emission topography (PET). Upon administration, the W372 moiety of fluorine F 18 W372 selectively targets and binds to amyloid-beta in the brain. Upon binding, amyloid-beta plaques can be visualized and detected during PET imaging. Amyloid-beta accumulates in the brain and is a key component in plaque formation in Alzheimer's disease.
| Identifier | MLC-T-ONC-013700 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | [F-18] W372; [F-18]W372; [18F]-W372 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013700",
"term": "fluorine F 18 W372",
"field": "Oncology and biomedicine",
"definition": "A radiotracer composed of W372 radiolabeled with the radioisotope fluorine F 18, with potential amyloid-beta (Abeta) peptide imaging activity upon positron emission topography (PET). Upon administration, the W372 moiety of fluorine F 18 W372 selectively targets and binds to amyloid-beta in the brain. Upon binding, amyloid-beta plaques can be visualized and detected during PET imaging. Amyloid-beta accumulates in the brain and is a key component in plaque formation in Alzheimer's disease.",
"synonyms": [
"[F-18] W372",
"[F-18]W372",
"[18F]-W372"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fluorine-f-18-w372/"
}
Record 7,450 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.